Thrivent Financial For Lutherans Bristol Myers Squibb CO Transaction History
Thrivent Financial For Lutherans
- $51.6 Billion
- Q4 2024
A detailed history of Thrivent Financial For Lutherans transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 166,479 shares of BMY stock, worth $8.2 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
166,479
Previous 116,801
42.53%
Holding current value
$8.2 Million
Previous $6.04 Million
56.35%
% of portfolio
0.02%
Previous 0.01%
Shares
31 transactions
Others Institutions Holding BMY
# of Institutions
2,777Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$9.35 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.81 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$4.73 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$4.68 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$2.97 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $105B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...